BSECompany Update9 Oct 2026 · 9 Oct 2026, 02:41 pm
Intimation of investor(s) meeting(s) to be held on October 14, 2026.
Fermenta Biotech Ltd · 506414
✦ AI SummaryMgmt Change
Fermenta Biotech Ltd has announced an investor meeting on October 14, 2026, where the company officials will interact with individual investors. The meeting will be held physically in Mumbai. The company has made available relevant press releases and investor presentations on its website and stock exchange websites, and no unpublished price-sensitive information will be discussed during the interaction.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
0a4d918d-b37e-4cae-9105-1eb45f704a83.pdf
View document text
October 09, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1,
Dalal Street, Fort, G Block, Bandra - Kurla Complex,
Mumbai – 400 001 Bandra (East), Mumbai 400 051
Scrip Code: 506414 Trading Symbol: FERMENTA
Sir,
Subject: Intimation of investor(s) meeting(s).
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations
2015, we request you to note that the Company, through its officials, will be participating in
meeting(s) with investor(s), details of which are as below:
Date Type of meeting Mode Location
October 14, 2026 One-to-One meeting(s) with Physical Mumbai
3 individual investor(s)
This is to further inform that the relevant Press Releases and Investor Presentations proposed to
be discussed with investor(s) in above interaction(s) are as available on the website of the
Company - www.fermentabiotech.com and of stock exchange(s) on which the Company’s shares
are listed, and no unpublished price sensitive information (UPSI) is intended to be discussed
during the interaction(s).
Kindly note that changes may happen due to exigencies on the part of the Company/investor(s).
Thanking you,
Yours faithfully,
for FERMENTA BIOTECH LIMITED
Varadvinayak Khambete
Company Secretary & Head – Legal
Membership No. A33861